Eastwood Bio-Medical Canada Inc. (EWOOF) Research

Eastwood Bio-Medical Canada Inc. specializes in the marketing and distribution of natural health products under its proprietary Eleotin brand. The company's reach extends across Canada, the United States, and Asia. Its primary focus is on providing natural remedies for metabolic health concerns, such as blood glucose imbalances, high blood pressure, and obesity. The diverse Eleotin product range includes several licensed formulations: Eleotin A 700: Addresses spleen deficiency, poor appetite, and fatigue. Eleotin AL88: Functions as a laxative. Eleotin Cal20 & V3D: Both contribute to the development and maintenance of healthy bones and teeth, with V3D additionally promoting overall good health. Eleotin G2000: Supports cardiovascular well-being. Eleotin H55: Offers sedative effects and helps alleviate tension. Eleotin Zn330: Aids in tissue formation and metabolism. Additionally, the company offers Eleotin Bentley to assist in maintaining healthy glucose levels and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was founded in 2010 and is based in Richmond, Canada.

Market snapshot

Symbol
EWOOF
Price
$0.69
Market cap
$67.7M
P/E ratio
-123.95x
Sector
Consumer Defensive
Industry
Food Distribution

Peer companies

  • AiXin Life International, Inc. (AIXN)
  • The Good Flour Corp. (GFCOF)
  • House of Jane, Inc. (HOJI)
  • Industrias Bachoco, S.A.B. de C.V. (IDBHF)
  • LARK Distilling Co. Ltd. (LRKKF)
  • Hawaiian Macadamia Nut Orchards, L.P. (NNUTU)
  • Performance Drink Group, Inc. (PDPG)
  • Raffles Education Limited (RFLFY)

Open Eastwood Bio-Medical Canada Inc. (EWOOF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.